Skip to main content

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.

Publication ,  Journal Article
Luo, N; Xu, H; Jneid, H; Fonarow, GC; Lopes, RD; Piccini, JP; Curtis, AB; Russo, AM; Lewis, WR; Matsouaka, RA; Granger, CB; Mentz, RJ; Al-Khatib, SM
Published in: Circ Heart Fail
October 2018

BACKGROUND: Stroke prophylaxis in patients with atrial fibrillation (AF) and heart failure (HF) in the era of direct oral anticoagulants is not well characterized. Using data from American Heart Association Get With The Guidelines-AFIB, we sought to evaluate oral anticoagulation (OAC) use at discharge among AF patients with concomitant HF. METHODS AND RESULTS: AF patients with a diagnosis of HF hospitalized from January 2013 to March 2017 were included. We compared patient characteristics and use of OAC at discharge among patients with reduced (redundant ejection fraction [EF], EF≤40%), borderline (40%

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

October 2018

Volume

11

Issue

10

Start / End Page

e005356

Location

United States

Related Subject Headings

  • Warfarin
  • Risk Factors
  • Practice Patterns, Physicians'
  • Patient Discharge
  • Humans
  • Heart Failure
  • Female
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anticoagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luo, N., Xu, H., Jneid, H., Fonarow, G. C., Lopes, R. D., Piccini, J. P., … Al-Khatib, S. M. (2018). Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail, 11(10), e005356. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005356
Luo, Nancy, Haolin Xu, Hani Jneid, Gregg C. Fonarow, Renato D. Lopes, Jonathan P. Piccini, Anne B. Curtis, et al. “Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.Circ Heart Fail 11, no. 10 (October 2018): e005356. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005356.
Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, et al. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail. 2018 Oct;11(10):e005356.
Luo, Nancy, et al. “Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation.Circ Heart Fail, vol. 11, no. 10, Oct. 2018, p. e005356. Pubmed, doi:10.1161/CIRCHEARTFAILURE.118.005356.
Luo N, Xu H, Jneid H, Fonarow GC, Lopes RD, Piccini JP, Curtis AB, Russo AM, Lewis WR, Matsouaka RA, Granger CB, Mentz RJ, Al-Khatib SM. Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation. Circ Heart Fail. 2018 Oct;11(10):e005356.

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

October 2018

Volume

11

Issue

10

Start / End Page

e005356

Location

United States

Related Subject Headings

  • Warfarin
  • Risk Factors
  • Practice Patterns, Physicians'
  • Patient Discharge
  • Humans
  • Heart Failure
  • Female
  • Cardiovascular System & Hematology
  • Atrial Fibrillation
  • Anticoagulants